A double-blind, placebo controlled, randomized, parallel-group clinical trial with multiple dose treatment of anti-IL [interleukin] 15 human monoclonal antibody (AMG 714) in patients with active rheumatoid arthritis who have previously failed one or more disease modifying anti-rheumatic drugs
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2007
At a glance
- Drugs AMG 714 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 12 Mar 2007 New trial record.